186 related articles for article (PubMed ID: 21928456)
1. Urchin-shaped manganese oxide nanoparticles as pH-responsive activatable T1 contrast agents for magnetic resonance imaging.
Kim T; Cho EJ; Chae Y; Kim M; Oh A; Jin J; Lee ES; Baik H; Haam S; Suh JS; Huh YM; Lee K
Angew Chem Int Ed Engl; 2011 Nov; 50(45):10589-93. PubMed ID: 21928456
[No Abstract] [Full Text] [Related]
2. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
[TBL] [Abstract][Full Text] [Related]
3. pH-Activatable MnO-Based Fluorescence and Magnetic Resonance Bimodal Nanoprobe for Cancer Imaging.
Hsu BY; Ng M; Tan A; Connell J; Roberts T; Lythgoe M; Zhang Y; Wong SY; Bhakoo K; Seifalian AM; Li X; Wang J
Adv Healthc Mater; 2016 Mar; 5(6):721-9. PubMed ID: 26895111
[TBL] [Abstract][Full Text] [Related]
4. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery.
Shin J; Anisur RM; Ko MK; Im GH; Lee JH; Lee IS
Angew Chem Int Ed Engl; 2009; 48(2):321-4. PubMed ID: 19040234
[No Abstract] [Full Text] [Related]
5. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
Na HB; Lee JH; An K; Park YI; Park M; Lee IS; Nam DH; Kim ST; Kim SH; Kim SW; Lim KH; Kim KS; Kim SO; Hyeon T
Angew Chem Int Ed Engl; 2007; 46(28):5397-401. PubMed ID: 17357103
[No Abstract] [Full Text] [Related]
6. Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform.
Ha TL; Kim HJ; Shin J; Im GH; Lee JW; Heo H; Yang J; Kang CM; Choe YS; Lee JH; Lee IS
Chem Commun (Camb); 2011 Aug; 47(32):9176-8. PubMed ID: 21761053
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of MnxFe1-xO colloidal solid solution as a dual magnetic-resonance-contrast agent.
Choi D; Han A; Park JP; Kim JK; Lee JH; Kim TH; Kim SW
Small; 2009 Mar; 5(5):571-3. PubMed ID: 19089842
[No Abstract] [Full Text] [Related]
8. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
9. Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.
Cai X; Zhu Q; Zeng Y; Zeng Q; Chen X; Zhan Y
Int J Nanomedicine; 2019; 14():8321-8344. PubMed ID: 31695370
[TBL] [Abstract][Full Text] [Related]
10. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
11. Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents.
Wang X; Niu D; Wu Q; Bao S; Su T; Liu X; Zhang S; Wang Q
Biomaterials; 2015; 53():349-57. PubMed ID: 25890733
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
[TBL] [Abstract][Full Text] [Related]
13. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.
Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A
Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519
[TBL] [Abstract][Full Text] [Related]
14. Tunable Performance of Manganese Oxide Nanostructures as MRI Contrast Agents.
Bañobre-López M; García-Hevia L; Cerqueira MF; Rivadulla F; Gallo J
Chemistry; 2018 Jan; 24(6):1295-1303. PubMed ID: 29178467
[TBL] [Abstract][Full Text] [Related]
15. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.
Kim MH; Son HY; Kim GY; Park K; Huh YM; Haam S
Biomaterials; 2016 Sep; 101():121-30. PubMed ID: 27281684
[TBL] [Abstract][Full Text] [Related]
16. A Prussian Blue-Based Core-Shell Hollow-Structured Mesoporous Nanoparticle as a Smart Theranostic Agent with Ultrahigh pH-Responsive Longitudinal Relaxivity.
Cai X; Gao W; Ma M; Wu M; Zhang L; Zheng Y; Chen H; Shi J
Adv Mater; 2015 Nov; 27(41):6382-9. PubMed ID: 26393889
[TBL] [Abstract][Full Text] [Related]
17. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.
Chen Y; Yin Q; Ji X; Zhang S; Chen H; Zheng Y; Sun Y; Qu H; Wang Z; Li Y; Wang X; Zhang K; Zhang L; Shi J
Biomaterials; 2012 Oct; 33(29):7126-37. PubMed ID: 22789722
[TBL] [Abstract][Full Text] [Related]
18. Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging.
Li Z; Wang SX; Sun Q; Zhao HL; Lei H; Lan MB; Cheng ZX; Wang XL; Dou SX; Max Lu GQ
Adv Healthc Mater; 2013 Jul; 2(7):958-64. PubMed ID: 23322490
[No Abstract] [Full Text] [Related]
19. Bifunctional Pyrrolidin-2-one Terminated Manganese Oxide Nanoparticles for Combined Magnetic Resonance and Fluorescence Imaging.
Banerjee A; Bertolesi GE; Ling CC; Blasiak B; Purchase A; Calderon O; Tomanek B; Trudel S
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13069-13078. PubMed ID: 30883086
[TBL] [Abstract][Full Text] [Related]
20. Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery.
Chen Y; Chen H; Zhang S; Chen F; Sun S; He Q; Ma M; Wang X; Wu H; Zhang L; Zhang L; Shi J
Biomaterials; 2012 Mar; 33(7):2388-98. PubMed ID: 22177841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
